Search Login Register

Islet Cell Carcinoma Summary

Description: A primary malignant neoplasm of the pancreatic ISLET CELLS. Usually it involves the non-INSULIN-producing cell types, the PANCREATIC ALPHA CELLS and the pancreatic delta cells (SOMATOSTATIN-SECRETING CELLS) in GLUCAGONOMA and SOMATOSTATINOMA, respectively.

Also Known As: Carcinoma, Islet Cell; Carcinomas, Islet Cell; Islet Cell Carcinomas; Islet Cell Tumor, Malignant

Networked: 143 relevant articles (5 outcomes, 16 trials/studies) for this Disease

Key Drugs and Agents for Islet Cell Carcinoma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Streptozocin (Streptozotocin) : 1 outcome 4 studies in 29 results : FDA 1
  2. Doxorubicin (Adriamycin) : 1 outcome 4 studies in 7 results : FDA 12 Generic
  3. Fluorouracil (Carac) : 1 outcome 3 studies in 10 results : FDA 33 Generic
  4. Octreotide (Sandostatin) : 1 outcome 1 study in 8 results : FDA 14 Generic
  5. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor) : 1 outcome 1 study in 1 result : IBA
  6. Hormones : 2 studies in 10 results : IBA
  7. chlorozotocin : 2 studies in 4 results : IBA
  8. Gastrins : 1 study in 13 results : IBA
  9. Insulin (Novolin) : 1 study in 11 results : FDA 2
  10. Somatostatin (Somatotropin Release-Inhibiting Factor) : 1 study in 10 results : IBA
Show All >>

Diseases Related to Islet Cell Carcinoma

  1. Carcinoid Tumor (Carcinoid)
  2. Neoplasms (Cancer)
  3. Thyroid Neoplasms (Thyroid Cancer)
  4. Neoplasm Metastasis (Metastasis)
  5. Medullary Carcinoma
Show All >>

Key Therapies for Islet Cell Carcinoma

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 1 outcome in 10 results
  2. Radiotherapy : 1 outcome in 2 results
  3. Transplantation (Transplant Recipients) : 1 outcome in 1 result
  4. Pancreatectomy : 1 study in 6 results
  5. Liver Transplantation : 1 study in 2 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.